Example: Heart Attack

Search clinical trials for: Flumazenil

Total 35 results

NCT02048969

Withdrawn

Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS

Conditions: Hepatic Encephalopathy; Liver Cirrhosis
NCT02899156

Terminated

Flumazenil for Hypoactive Delirium Secondary to Benzodiazepine Exposure

Conditions: Hypoactive Delirium
NCT01183312

Completed

Flumazenil for the Treatment of Primary Hypersomnia

Conditions: Hypersomnia; Primary Hypersomnia; Idiopathic Hypersomnia; Narcolepsy Without Cataplexy
NCT03462641

Recruiting

Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm

Conditions: Parkinson Disease
NCT02157428

Completed

Effect of Flumazenil on Recovery From General Anesthesia With Isoflurane

Conditions: Adverse Effect of Other General Anesthetics
NCT00997087

Terminated

A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder

Conditions: Obsessive Compulsive Disorder
NCT01071889

Completed

Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults

Conditions: Healthy
NCT02690389

Completed

Electro-acupuncture and Flumazenil's Effect on Sedation

Conditions: Acupuncture; General Anaesthesia; Sedation
NCT01655914

Completed

Safety and Pharmacokinetic Study of Sublingual Flumazenil (CRLS035) in Healthy Adults

Conditions: Insomnia
NCT00695630

Completed

Flumazenil Reversal of Oral Triazolam

Conditions: Dental Anxiety
NCT01904487

Completed

Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence

Conditions: Alcoholism
NCT03825601

Not yet recruiting

PET With [18F]Flumazenil as an Index of Neurodegeneration in MS

Conditions: Multiple Sclerosis; Relapsing-Remitting Multiple Sclerosis
NCT00000246

Completed

Rapid Benzodiazepine Detoxification Using Flumazenil - 1

Conditions: Substance-Related Disorders
NCT01651520

Unknown status

Prognosis Value of the Neuronal Damage in Early Multiple Sclerosis

Conditions: Multiple Sclerosis
NCT00681746

Completed

Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280

Conditions: Anxiety
NCT00681720

Completed

Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325

Conditions: Anxiety
NCT03743805

Recruiting

Rapid Reversal of CNS-Depressant Drug Effect Prior to Brain Death Determination

Conditions: Brain Death; Anoxic Brain Injury; Cardiac Arrest; Sedative Intoxication; Narcotic Intoxication
NCT00262639

Completed

Prometa Protocol for Alcohol Dependence

Conditions: Alcohol Dependence
NCT04308954

Recruiting

Neuroimaging GABA Physiology in Fragile X Syndrome

Conditions: Fragile X Syndrome (FXS); Idiopathic Intellectual Developmental Disorder (IDD)
NCT03440112

Recruiting

Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm

Conditions: Parkinson Disease
NCT04329585

Recruiting

GABA Antagonist to Improve Reversal of Anesthesia With High-density EEG Surveillance

Conditions: Moderate Sedation; Colonoscopy
NCT00015678

Completed

Effects of Flumazenil on Brain Excitability

Conditions: Stroke; Healthy
NCT02696512

Unknown status

A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness

Conditions: Brain Injury
NCT00570388

Unknown status

Neurocognitive Functioning Following The PROMETA® Treatment Protocol In Subjects With Alcohol Dependence

Conditions: Alcohol Dependence
NCT01547819

Withdrawn

Mild Traumatic Brain Injury and Post-Traumatic Stress Disorder

Conditions: Posttraumatic Stress Disorder; Traumatic Brain Injury